Speaker illustration

Assistant Professor Axel Schlitt

Paracelsus Harz Clinic Bad Suderode, Quedlinburg (Germany)

Member of:

European Society of Cardiology

The current LDL-C target <1.4mmol/l of the ESC is achieved in less than 16% of patients with Coronary Heart Disease despite effective lipid-lowering therapy: Data from the LLT-R registry

Event: ESC Congress 2020

Topic: Drug therapy

Session: Risk Factors and Prevention ePosters

Thumbnail

Progonosis of patients with pulmonary embolism after rehabilition

Event: ESC Congress 2018

Topic: Outcomes

Session: Best Posters in cardiovascular rehabilitation

Thumbnail

Impact of national cardiac, cardiac surgery and intensive care conferences on cardiovascular mortality in Germany

Event: ESC Congress 2016

Topic: Public health and health policy

Session: Prevention and management across the world

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb